284620 — Kainos Medicine Balance Sheet
0.000.00%
- KR₩35bn
- KR₩35bn
- KR₩267m
Annual balance sheet for Kainos Medicine, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 10,598 | 29,812 | 34,231 | 29,952 | 16,337 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 99.8 | 82.9 | 300 | 329 | 207 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 10,697 | 31,987 | 36,873 | 31,236 | 17,117 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | — | 1,851 | 3,334 | 5,437 | 875 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 10,697 | 34,779 | 41,957 | 38,982 | 20,985 |
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.624 | 4,167 | 25,655 | 8,678 | 5,129 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 790 | 22,426 | 29,853 | 12,873 | 9,234 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Other Equity | |||||
Total Equity | 9,907 | 12,353 | 12,104 | 26,109 | 11,751 |
Total Liabilities & Shareholders' Equity | 10,697 | 34,779 | 41,957 | 38,982 | 20,985 |
Total Common Shares Outstanding |